NOVEL - Journal of Neuro-Ophthalmology
 
Filters: Collection: "ehsl_novel_jno" Subject: "Quality of Life"
1 - 25 of 16
Number of results to display per page
TitleCreatorDate
1 Clinical outcome Measures for Research in Multiple SclerosisBalcer, LJ
2 Clinical Trials to Clinical Use: Using Vision as a Model for Multiple Sclerosis and BeyondLaura J. Balcer, MD, Professor, Department of Neurology, NYU Langone
3 Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi ApproachRaymond S. Douglas, Andrea L. Kossler, Jody Abrams, Cesar A. Briceño, David Gay, Andrew Harrison, Michael Lee, John Nguyen, Shannon S. Joseph, Dianne Schlachter, Jeremy Tan, Judah Lynch, Louisa Oliver, Richard Perry, Shoaib Ugradar2022-09
4 Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialKimberly E. Cello, BS, John L. Keltner, MD, Chris A. Johnson, PhD, Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
5 Impact of Greater Occipital Nerve Block on Photophobia Levels in Migraine PatientsJavier A Membrilla, Íñigo de Lorenzo, Lucía Sánchez-Casado, María Sastre, Javier Díaz de Terán2022-09
6 The Impact of Leber Hereditary Optic Neuropathy on the Quality of Life of Patients and Their Relatives: A Qualitative StudyBenson S. Chen, Erik Holzinger, Magali Taiel, Patrick Yu-Wai-Man2022-09
7 More Than Meets the Eye: The Eye and Migraine -- What You Need to KnowKathleen B. Digre, MD2018-06
8 Rehabilitation of Visual Loss: Where We Are and Where We Need to BeBehzad Mansouri, MD, PhD, FRCPC, Marinya Roznik, BSc, Joseph F. Rizzo III, MD,Sashank Prasad, MD2018-06
9 Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment TrialMartin W. ten Hove, MD, Deborah I. Friedman, MD, Anil D. Patel, MD, Isabella Irrcher, PhD, Michael Wall, MD, Michael P. McDermott, PhD, for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
10 Sharp Edge Eye Syndrome: A Case Report and Survey of Self-Identified IndividualsMerrick S. Reynolds; Bradley J. Katz; Kathleen B. Digre, Ben J. Brintz; Lenora M. Olson; Judith E. A. Warner2022-12
11 The SKILL Card Test in Optic NeuritisLong, DT; Beck, RW; Moke, PS; Blair, RC; Kip, KE; Gal, RL; Katz, BJ
12 Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of LifeSalim Chahin; Laura J Balcer; Deborah M Miller; Annie Zhang; Steven L Galetta
13 Vision in Multiple Sclerosis: The Story, Structure-Function Correlations, and Models for NeuroprotectionSakai, Reiko E; Feller Daniel J; Galetta, Kristin M; Galetta, Steven L; Balcer, Laura J
14 Visual Function and Quality of Life Among Patients with Giant Cell ArteritisKupersmith, MJ; Speira, R; Langer, R; Richmond, M; Peterson, M; Speira, H; Mitnick, H; Paget, S
15 Visual Pathway Axonal Loss in Benign Multiple SclerosisGaletta, Kristin M; Graves, Jennifer; Talman, Lauren S; Lile, Deacon J; Frohman, Elliot M; Calabresi, Peter A; Galetta, Steven L; Balcer, Laura J
16 Visual Symptoms after Optic NeuritisCleary, PA; Beck, RW; Bourque, LB; Backlund, JC; Miskala, PH
1 - 25 of 16